These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 33065552)

  • 1. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA.
    Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
    Aging (Albany NY); 2020 Oct; 12(20):20085-20094. PubMed ID: 33065552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
    BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
    Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
    Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor Aspirin vs Clopidogrel Aspirin in
    Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
    Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
    Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
    Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor versus Clopidogrel in
    Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B;
    N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA.
    Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
    Front Neurol; 2020; 11():534. PubMed ID: 32587571
    [No Abstract]   [Full Text] [Related]  

  • 10. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in
    Meng X; Wang A; Tian X; Johnston C; Li H; Bath PM; Xu Q; Zhang Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang Y
    Neurology; 2024 Feb; 102(3):e207809. PubMed ID: 38181311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
    Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Cao Y; Wang Y
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2074-2081. PubMed ID: 28736132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of smoking on platelet function of ticagrelor versus clopidogrel in minor stroke or transient ischaemic attack.
    Yang Y; Chen W; Meng X; Liu L; Wang Y; Pan Y; Wang Y
    Eur J Neurol; 2020 May; 27(5):833-840. PubMed ID: 32052517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design.
    Wang Y; Lin Y; Meng X; Chen W; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Liu L; Zhao X; Wang Y;
    Int J Stroke; 2017 Apr; 12(3):321-325. PubMed ID: 28381198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: Systematic review and meta-analysis.
    Alakbarzade V; Huang X; Ster IC; McEntagart M; Pereira AC
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104877. PubMed ID: 32414579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin platelet reactivity on platelet function and clinical outcome in minor stroke or transient ischemic attack.
    Xu Y; Chen W; Jiang L; Wang Y; Zhao X; Liu L; Yao D; Guo L; Wang Y; Pan Y; Wang Y
    J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106683. PubMed ID: 35914511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack.
    Narasimhalu K; Chan J; Ang YK; De Silva DA; Tan KB
    Int J Stroke; 2024 Feb; 19(2):209-216. PubMed ID: 37679898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
    Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
    Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome.
    Peng W; Shi X; Xu X; Lin Y
    Cardiovasc Ther; 2019; 2019():3470145. PubMed ID: 31772608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention-treated Acute Coronary Syndrome Patients.
    Mohareb MW; AbdElghany M; Zaki HF; El-Abhar HS
    J Cardiovasc Pharmacol; 2020 Oct; 76(4):478-488. PubMed ID: 32675750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.